Goes to show the market knows that RAC is incredibly undervalued and you would have to be a fool to short us.
Let's not forget that we were sitting above $3 a share BEFORE our cardioprotective discovery.
Doesn't make much sense when the potential market for Zantrene doubled as stated by Dr T yet our share price has halved.
If I had anymore money I would still be buying but unfortunately Uni life doesn't give me such luxuries. I stay waiting for our eventual re-rate.
Goes to show the market knows that RAC is incredibly undervalued...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
0.000(0.00%) |
Mkt cap ! $208.5M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.26 | $8.042K | 6.408K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 6513 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 1127 | 3 |
View Market Depth
| Last trade - 10.07am 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.24 |
Change
0.000 ( 1.98 %) |
||||
| Open | High | Low | Volume | ||
| $1.25 | $1.25 | $1.24 | 1294 | ||
| Last updated 10.24am 01/05/2024 ? | |||||
| RAC (ASX) Chart |